Bayer Animal Health GmbH Sustainability Profile
Bayer Animal Health GmbH, a subsidiary of Bayer AG, is a leading player in the global animal health industry, headquartered in Leverkusen, Germany. Established in 1919, the company has consistently innovated in veterinary medicine, focusing on the health and well-being of livestock and companion animals. With a strong presence in Europe, North America, and Asia, Bayer Animal Health offers a diverse range of products, including pharmaceuticals, vaccines, and nutritional solutions. Their commitment to research and development has led to unique offerings that address various health challenges in animals. Recognised for its high-quality standards and effective solutions, Bayer Animal Health has achieved significant milestones, solidifying its position as a trusted partner for veterinarians and pet owners alike.
DitchCarbon Score
How does Bayer Animal Health GmbH's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Bayer Animal Health GmbH's score of 54 is higher than 74% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Bayer Animal Health GmbH, headquartered in Germany (DE), currently does not have specific carbon emissions data available for recent years. The company is a current subsidiary of Elanco Animal Health Incorporated, which influences its climate commitments and initiatives. As part of its corporate family relationship, Bayer Animal Health GmbH inherits climate-related targets and performance metrics from Elanco Animal Health Incorporated. However, no specific reduction targets or achievements have been documented for Bayer Animal Health GmbH itself. The absence of emissions data and reduction initiatives suggests that the company may still be in the process of establishing its own climate strategy. Bayer Animal Health GmbH's climate commitments are likely aligned with those of Elanco, which may include industry-standard practices and initiatives aimed at reducing carbon footprints. As the company develops its own sustainability framework, it is expected to adopt similar targets and strategies to address climate change effectively.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2015 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|
| Scope 1 | 274,550,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 418,271,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
How Carbon Intensive is Bayer Animal Health GmbH's Industry?
How Carbon Intensive is Bayer Animal Health GmbH's Location?
Bayer Animal Health GmbH's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Bayer Animal Health GmbH has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
